BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 23339300)

  • 1. Protein misfolding in disease and small molecule therapies.
    Gomes CM
    Curr Top Med Chem; 2012; 12(22):2460-9. PubMed ID: 23339300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases.
    Convertino M; Das J; Dokholyan NV
    ACS Chem Biol; 2016 Jun; 11(6):1471-89. PubMed ID: 27097127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the design of broad based screening assays to identify potential pharmacological chaperones of protein misfolding diseases.
    Naik S; Zhang N; Gao P; Fisher MT
    Curr Top Med Chem; 2012; 12(22):2504-22. PubMed ID: 23339304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels.
    Young JC
    Dis Model Mech; 2014 Mar; 7(3):319-29. PubMed ID: 24609033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling druggable signalling networks that control F508del-CFTR proteostasis.
    Hegde RN; Parashuraman S; Iorio F; Ciciriello F; Capuani F; Carissimo A; Carrella D; Belcastro V; Subramanian A; Bounti L; Persico M; Carlile G; Galietta L; Thomas DY; Di Bernardo D; Luini A
    Elife; 2015 Dec; 4():. PubMed ID: 26701908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis.
    van der Woerd WL; Wichers CG; Vestergaard AL; Andersen JP; Paulusma CC; Houwen RH; van de Graaf SF
    J Hepatol; 2016 Jun; 64(6):1339-47. PubMed ID: 26879107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
    Lindquist SL; Kelly JW
    Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in targeting protein misfolding diseases.
    Denny RA; Gavrin LK; Saiah E
    Bioorg Med Chem Lett; 2013 Apr; 23(7):1935-44. PubMed ID: 23454013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using pharmacological chaperones to restore proteostasis.
    Wang YJ; Di XJ; Mu TW
    Pharmacol Res; 2014 May; 83():3-9. PubMed ID: 24747662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics uncovering possible key players in F508del-CFTR processing and trafficking.
    Gomes-Alves P; Penque D
    Expert Rev Proteomics; 2010 Aug; 7(4):487-94. PubMed ID: 20653505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological correction of misfolding of ABC proteins.
    Rudashevskaya EL; Stockner T; Trauner M; Freissmuth M; Chiba P
    Drug Discov Today Technol; 2014 Jun; 12(100):e87-94. PubMed ID: 25027379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein misfolding diseases: Prospects of pharmacological treatment.
    Gámez A; Yuste-Checa P; Brasil S; Briso-Montiano Á; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
    Clin Genet; 2018 Mar; 93(3):450-458. PubMed ID: 28671287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein homeostasis as a therapeutic target for diseases of protein conformation.
    Calamini B; Morimoto RI
    Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules that target protein misfolding.
    Gavrin LK; Denny RA; Saiah E
    J Med Chem; 2012 Dec; 55(24):10823-43. PubMed ID: 23075044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of protein-folding diseases at a glance.
    Valastyan JS; Lindquist S
    Dis Model Mech; 2014 Jan; 7(1):9-14. PubMed ID: 24396149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein folding, misfolding, aggregation and their implications in human diseases: discovering therapeutic ways to amyloid-associated diseases.
    Iram A; Naeem A
    Cell Biochem Biophys; 2014 Sep; 70(1):51-61. PubMed ID: 24639112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.